.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The evidence for intradetrusor botulinum toxin in neurogenic bladder is particularly relevant to neurological patients who remain symptomatic despite oral therapy. Randomized data in multiple sclerosis and spinal cord injury demonstrate meaningful reductions in urinary incontinence and improved quality-of-life outcomes after onabotulinumtoxinA injections. The therapeutic effect is achieved locally within the detrusor, offering an alternative when antimuscarinic treatment is insufficient or poorly tolerated. The principal practical issue is that detrusor relaxation can increase post-void residuals and urinary retention, so clinicians must assess emptying and be prepared to teach intermittent catheterisation when required. The treatment is also temporary and generally needs repeat procedures. For HCPs, neurogenic bladder should be managed as a chronic neurological complication rather than as an isolated urological symptom. Continence, upper urinary tract protection, sexual function, infection risk and patient independence all matter. This evidence aligns closely with IANCON's neuro-urology workshop, which covers assessment of urinary symptoms, neurogenic bladder and sexual dysfunction in neurological disease.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The evidence for intradetrusor botulinum toxin in neurogenic bladder is particularly relevant to neurological patients who remain symptomatic despite oral therapy. Randomized data in multiple sclerosis and spinal cord injury demonstrate meaningful reductions in urinary incontinence and improved quality-of-life outcomes after onabotulinumtoxinA injections. The therapeutic effect is achieved locally within the detrusor, offering an alternative when antimuscarinic treatment is insufficient or poorly tolerated. The principal practical issue is that detrusor relaxation can increase post-void residuals and urinary retention, so clinicians must assess emptying and be prepared to teach intermittent catheterisation when required. The treatment is also temporary and generally needs repeat procedures. For HCPs, neurogenic bladder should be managed as a chronic neurological complication rather than as an isolated urological symptom. Continence, upper urinary tract protection, sexual function, infection risk and patient independence all matter. This evidence aligns closely with IANCON's neuro-urology workshop, which covers assessment of urinary symptoms, neurogenic bladder and sexual dysfunction in neurological disease.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
